This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: University of California. Active years: 2015-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2020
Title: Innovations of Inventor Jessica Shu
Introduction
Jessica Shu is a prominent inventor based in San Francisco, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of novel drug delivery systems. With a total of 3 patents, her work has garnered attention for its potential applications in medicine.
Latest Patents
One of her latest patents is focused on bis-polymer lipid-peptide conjugates and nanoparticles thereof. This invention provides bis-polymer lipid-peptide conjugates that contain a hydrophobic block and a headgroup featuring a helical peptide along with two polymer blocks. The conjugates are designed to self-assemble into helix bundle subunits, which can further assemble to create micellar nanocarriers for drug cargos and other agents. The patent also discloses methods for forming these particles, showcasing her innovative approach to drug delivery.
Career Highlights
Jessica Shu is affiliated with the University of California, where she continues to advance her research in the field. Her work is characterized by a strong emphasis on the intersection of chemistry and biology, leading to breakthroughs that could enhance therapeutic efficacy.
Collaborations
Jessica has collaborated with notable colleagues, including Ting Xu and He Dong, who share her passion for innovation in biotechnology. Their combined expertise contributes to the advancement of their research projects and the development of new technologies.
Conclusion
Jessica Shu's contributions to the field of biotechnology through her innovative patents and collaborations highlight her role as a leading inventor. Her work promises to impact drug delivery systems significantly, paving the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
